Optimizing Treatment Strategies for Potentially Resectable mCRC Patients

In managing metastatic colorectal cancer (mCRC), particularly in cases with liver metastases, a tailored treatment strategy derived from comprehensive patient assessment is pivotal. Approximately 10% of patients are deemed upfront resectable, allowing for potentially curative surgery. In contrast, around 60% are categorized as unresectable, with treatment focused on prolonging survival and maintaining quality of life. Chemotherapy remains a critical component in the management of these patients, as outlined in the modified framework by Nordlinger et al. in Ann Oncol 2009.

• mcrc treatment
• liver metastases
• curative surgery
• patient assessment
• survival extension
• chemotherapy
• quality of life
• resectable patients

fleta + Follow